Compartilhar
Informação da revista
Vol. 90. Núm. 3.
Páginas 286-292 (maio - junho 2014)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Vol. 90. Núm. 3.
Páginas 286-292 (maio - junho 2014)
ARTIGO ORIGINAL
Open Access
Oxidant-antioxidant status in Egyptian children with sickle cell anemia: a single center based study
Estado oxidante-antioxidante em crianças egípcias com anemia falciforme: estudo baseado em um único centro
Visitas
4197
Mona Kamal El-Ghamrawya,
Autor para correspondência
melghamrawi@yahoo.com

Corresponding author.
, Wagdi Maurice Hannab, Amina Abdel-Salama, Marwa M. El-Sonbatyb, Eman R. Younessc, Ahmed Adelb
a Departamento de Pediatria, New Children's Hospital, Universidade do Cairo, Cairo, Egito
b Departamento de Saúde Infantil, Centro Nacional de Pesquisa, Cairo, Egito
c Departamento de Bioquímica Médica, Centro Nacional de Pesquisa, Cairo, Egito
Este item recebeu

Under a Creative Commons license
Informação do artigo
Resume
Bibliografia
Baixar PDF
Estatísticas
Abstract
Objective

the present study was conducted to investigate the oxidant-antioxidant status in Egyptian children with sickle cell anemia.

Methods

the serum levels of total antioxidant capacity (TAO), paraoxonase (PON), vitamin E, nitrite, and malondialdehyde (MDA) were measured in 40 steady state children with homozygoussickle cell anemia (24 males and 16 females) and 20 apparently healthy age- and gender-matched controls

Results

mean serum TAO, PON, vitamin E, and nitrite levels were significantly lower in thegroup with sickle cell anemia, whereas mean serum MDA was significantly higher in these children compared to controls. No significant differences in mean levels of TAO, PON, nitrite, vitamin E, and MDA were found in sickle cell anemia patients receiving hydroxyurea when com-pared with those not receiving hydroxyurea. A significant negative correlation between serumnitrite and the occurrence of vaso-occlusive crises (VOC) was observed (r = −0.3, p = 0.04). PON level was found to be positively correlated with patients’ weight and BMI (r = −0.4, p = 0.01; r = −0.7, p < 0.001, respectively), but not with frequency of VOC. The area under the curve ofserum nitrite in predicting occurrence of VOC was 0.782, versus 0.701 for PON, and 0.650 forTAO (p = 0.006). Serum MDA was not correlated with nitrite, PON, TAO, or vitamin E levels. No significant correlations were detected between serum nitrite and hemoglobin or antioxidant enzymes.

Conclusion

children with sickle cell anemia have chronic oxidative stress that may result inincreased VOC, and decreased serum nitrite may be associated with increases in VOC frequency. A novel finding in this study is the decrease in PON level in these patients, which is an interesting subject for further research.

Keywords:
Antioxidants
Nitrite
Paraoxonase
Malondialdehyde
Sickle cell anemia
Children
Resumo
Objetivo

o presente estudo foi realizado com o objetivo de investigar o estado oxidan- te-antioxidante em crianc¸as egípcias com anemia falciforme.

Métodos

dosamos os níveis séricos da capacidade antioxidante total (CAT), paraoxonase (PON), vitamina E, nitrito e malondialdeído (MDA) em 40 crianças estáveis com anemia falciforme homozigótica (24 meninos e 16 meninas), e 20 controles pareados por idade/sexo aparente-mente saudáveis.

Resultados

os níveis séricos médios da CAT, PON, vitamina E e nitrito foram significati- vamente menores, ao passo que o nível sérico médio de MDA foi significativamente maior em crianças com anemia falciforme (AF), em comparação aos controles. Não foram encontradasdiferenças significativas nos níveis médios de CAT, PON, nitrito, vitamina E e MDA em pacientescom AF em tratamento com hidroxiureia, em comparação aos que receberam hidroxiureia. Encontramos uma correlação negativa significativa entre o nitrito sérico e a ocorrência decrises vaso-oclusivas agudas (CVO) (r = −0,3, p = 0,04). Descobrimos que o nível de PON está correlacionado positivamente com o peso e o IMC dos pacientes (r = −0,4; p = 0,01; r = −0,7; p < 0,001, respectivamente), porém não com a frequência de CVO. A área sob a curva (ASC) donitrito sérico na previsão da ocorrência de CVO foi 0,782, em comparação a 0,701 para PON e 0,650 para CAT (p = 0,006). O MDA não está correlacionado a nitrito, PON, CAT ou vitamina E. Não foram detectadas correlações significativas entre nitrito sérico e hemoglobina ou enzimas antioxidantes.

Conclusão

crianças com AF apresentam estresse oxidativo crônico que pode resultar emaumento das CVO. Em crianças com AF, a redução nos níveis de nitrito sérico pode estar associada a aumentos da frequência de CVO. Um novo achado neste estudo é a redução no nível de PON em pacientes com AF, que é um campo interessante de novas pesquisas.

Palavras-chave:
Antioxidantes
Nitrito
Paraoxonase
Malondialdeído
Anemia falciforme
Crianças
O texto completo está disponível em PDF
Referências
[1]
D. Weatherall, K. Hofman, G. Rodgers, J. Ruffin, S. Hrynkow.
A case for developing North-South partnerships for research in sickle cell disease.
Blood., 105 (2005), pp. 921-923
[2]
M.H. Steinberg.
Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches.
ScientificWorldJournal., 8 (2008), pp. 1295-1324
[3]
D. Ray, P. Deshmukh, K. Goswami, N. Garg.
Antioxidant vitamin levels in sickle cell disorders.
Natl Med J India., 20 (2007), pp. 11-13
[4]
K.C. Wood, D.N. Granger.
Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
Clin Exp Pharmacol Physiol., 34 (2007), pp. 926-932
[5]
K.C. Wood, R.P. Hebbel, D.N. Granger.
Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice.
FASEB J., 19 (2005), pp. 989-991
[6]
P.P. Landburg, T. Teerlink, B.J. Biemond, D.P. Brandjes, F.A. Muskiet, A.J. Duits, et al.
Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype.
Blood Cells Mol Dis., 44 (2010), pp. 229-232
[7]
C.R. Morris, G.J. Kato, M. Poljakovic, X. Wang, W.C. Blackwelder, V. Sachdev, et al.
Dysregulated arginine metabolism, hemolysis- associated pulmonary hypertension, and mortality in sickle cell disease.
JAMA., 294 (2005), pp. 81-90
[8]
D.K. Kaul, X.D. Liu, X. Zhang, L. Ma, C.J. Hsia, R.L. Nagel.
Inhibition of sickle red cell adhesion and vasoocclusion in the microcirculation by antioxidants.
Am J Physiol Heart Circ Physiol., 291 (2006), pp. H167-H175
[9]
R.B. Francis Jr., C.S. Johnson.
Vascular occlusion in sickle cell disease: current concepts and unanswered questions.
Blood., 77 (1991), pp. 1405-1414
[10]
A.M. Emokpae, U.P. Ojiefo, K.G. Aisha.
Antioxidant enzymes and acute phase proteins correlate with marker of lipid peroxide in adult Nigerian sickle cell disease patients.
Iran J Basic Med Sci., 13 (2010), pp. 177-182
[11]
O.G. Arinola, S.A. Olaniyisa, M.O. Akibinu.
Evaluation of antioxidant levels and trace elements status in Nigerian sickle cell disease patients with plasmodium parasitae-mia.
Pak J Nut., 7 (2008), pp. 766-769
[12]
F. Foluke, A. Kayode, A. Johan, K. Modupe.
Total anti-oxidant status in sickle cell disease patients in steady state.
J Natl Med Assoc., 100 (2008), pp. 891-894
[13]
R.M. Hasanato.
Zinc and antioxidant vitamin deficiency in patients with severe sickle cell anemia.
Ann Saudi Med., 26 (2006), pp. 17-21
[14]
P.S. Hundekar, A.N. Suryakar, A.C. Karnik, R. Valvi, R.A. Ghone, S.S. Bhagat.
The effect of antioxidant supplementation on the oxidant and antioxidant status in sickle cell anemia.
J Clin Diag Res., 5 (2011), pp. 1339-1342
[15]
D.S. Darbari, O. Onyekwere, M. Nouraie, C.P. Minniti, L. Luchtman- Jones, S. Rana, et al.
Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia.
J Pediatr., 160 (2012), pp. 286-290
[16]
T.R. Kinney, R.W. Helms, E.E. O’Branski, K. Ohene-Frempong, W. Wang, C. Daeschner, et al.
Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial.
Pediatric Hydroxyurea Group. Blood., 94 (1999), pp. 1550-1554
[17]
M.B. Ruiz-Larrea, A.M. Leal, M. Liza, M. Lacort, H. de Groot.
Antioxidant effects of estradiol and 2-hydroxyestradiol on iron- induced lipid peroxidation of rat liver microsomes.
Steroids., 59 (1994), pp. 383-388
[18]
H. Moshage, B. Kok, J.R. Huizenga, P.L. Jansen.
Nitrite and nitrate determinations in plasma: a critical evaluation.
Clin Chem., 41 (1995), pp. 892-896
[19]
I. Guevara, J. Iwanejko, A. Dembińska-Kieć, J. Pankiewicz, A. Wanat, P. Anna, et al.
Determination of nitrite/nitrate in human biological material by the simple Griess reaction.
Clin Chim Acta., 274 (1998), pp. 177-188
[20]
A.D. Watson, J.A. Berliner, S.Y. Hama, B.N. La Du, K.F. Faull, A.M. Fogelman, et al.
Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
J Clin Invest., 96 (1995), pp. 2882-2891
[21]
O. Erel.
A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation.
Clin Biochem., 37 (2004), pp. 277-285
[22]
S.K. Jain, S.N. Levine, J. Duett, B. Hollier.
Reduced vitamin E and increased lipofuscin products in erythrocytes of diabetic rats.
Diabetes., 40 (1991), pp. 1241-1244
[23]
F. Yıldırım, K. Sermetow, A. Aycicek, A. Kocyigit, O. Erel.
Increased oxidative stress in preschool children exposed to passive smoking.
J Pediatr (Rio J)., 87 (2011), pp. 523-528
[24]
C.D. Reiter, M.T. Gladwin.
An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy.
Curr Opin Hematol., 10 (2003), pp. 99-107
[25]
M.H. Steinberg, F. Barton, O. Castro, C.H. Pegelow, S.K. Ballas, A. Kutlar, et al.
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
JAMA., 289 (2003), pp. 1645-1651
[26]
S.B. King.
Nitric oxide production from hydroxyurea.
Free Radic. Biol Med., 37 (2004), pp. 737-744
[27]
V.P. Cokic, R.D. Smith, B.B. Beleslin-Cokic, J.M. Njoroge, J.L. Miller, M.T. Gladwin, et al.
Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase.
J Clin Invest., 111 (2003), pp. 231-239
[28]
P.F. Teixeira Neto, R.P. Gonçalves, D.B. Elias, C.P. de Araújo, H.I. Magalhães.
Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceará, Brazil.
Rev Bras Hematol Hemoter., 33 (2011), pp. 207-210
[29]
S.L. Primo-Parmo, R.C. Sorenson, J. Teiber, B.N. La Du.
The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.
Genomics., 33 (1996), pp. 498-507
[30]
E. Amengual-Cladera, A. Nadal-Casellas, Y. Gómez-Pérez, I. Gomila, R.M. Prieto, A.M. Proenza, et al.
Phytotherapy in a rat model of hyperoxaluria: the antioxidant effects of quercetin involve serum paraoxonase 1 activation.
Exp Biol Med (Maywood)., 236 (2011), pp. 1133-1138
[31]
J. Kotur-Stevuljevic, S. Spasic, Z. Jelic-Ivanovic, V. Spasojevic- Kalimanovska, A. Stefanovic, A. Vujovic, et al.
PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
Clin Biochem., 41 (2008), pp. 1067-1073

Como citar este artigo: El-Ghamrawy MK, Hanna WM, Abdel-Salam A, El-Sonbaty MM, Youness ER, Adel A. Oxidant-antioxidant status in Egyptian children with sickle cell anemia: a single center based study. J Pediatr (Rio J).2014;90:286-92.

Copyright © 2014. Brasileira de Pediatria
Baixar PDF
Idiomas
Jornal de Pediatria
Opções de artigo
Ferramentas
en pt
Taxa de publicaçao Publication fee
Os artigos submetidos a partir de 1º de setembro de 2018, que forem aceitos para publicação no Jornal de Pediatria, estarão sujeitos a uma taxa para que tenham sua publicação garantida. O artigo aceito somente será publicado após a comprovação do pagamento da taxa de publicação. Ao submeterem o manuscrito a este jornal, os autores concordam com esses termos. A submissão dos manuscritos continua gratuita. Para mais informações, contate assessoria@jped.com.br. Articles submitted as of September 1, 2018, which are accepted for publication in the Jornal de Pediatria, will be subject to a fee to have their publication guaranteed. The accepted article will only be published after proof of the publication fee payment. By submitting the manuscript to this journal, the authors agree to these terms. Manuscript submission remains free of charge. For more information, contact assessoria@jped.com.br.
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.